SEC Form 4 · accession 0000902664-17-002041
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Qingqing Yi
Director
Period of report
Apr 19, 2017
Accepted (ET)
Apr 21, 2017 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1,F2 | $2.84 | Apr 19, 2017 | A | 199,992 | A | — | Apr 18, 2027 | Ordinary Shares | 199,992 | 199,992 | D |
Explanation of responses
- F1In ordinary shares. One American Depositary Share represents 13 ordinary shares.
- F2The option shall become exercisable in equal installments on the first, second and third anniversary of the grant date and shall become exercisable in full on the date of the third annual meeting of shareholders following the grant date. All vesting shall cease if the Reporting Person resigns from the Issuer's board of directors or otherwise ceases to serve as a director, unless the Issuer's board of directors determines that the circumstances warrant the continuation of vesting.
Remarks
Qingqing Yi ("Mr. Yi") is an employee of Hillhouse Capital Management, Ltd. ("Hillhouse Capital"). Hillhouse Capital acts as the sole general partner of YHG Investment, L.P. ("YHG") and the sole management company of Gaoling Fund, L.P. ("Gaoling") and Hillhouse Fund II, L.P. ("Fund II"). Fund II owns Hillhouse BGN Holdings Limited ("HH BGN"), and each of HH BGN, Gaoling and Fund II (collectively, the "Hillhouse Entities") hold securities of the Issuer. Mr. Yi expressly disclaims beneficial ownership of the securities held by the Hillhouse Entities, except to the extent of his pecuniary interest therein, if any.